Welcome to our dedicated page for Wiley (JOHN) & Sons news (Ticker: WLYB), a resource for investors and traders seeking the latest updates and insights on Wiley (JOHN) & Sons stock.
John Wiley & Sons, Inc. (NYSE: WLY, WLYB) regularly issues news that focuses on its role in authoritative content, research intelligence, and knowledge services for science and learning. Company announcements highlight how Wiley’s Research and Learning segments perform over time, with particular attention to trends in research publishing, open access, AI licensing projects, and market conditions in academic and professional learning.
Investors and researchers following WLYB news will see detailed earnings releases that discuss revenue by segment, adjusted operating income, Adjusted EBITDA, Adjusted EPS, and cash flow measures. These releases often describe demand to publish, read, and license research content, article submission and output trends, and the balance between recurring revenue models and open access publishing. They also cover Learning segment dynamics, including shifts between print and digital formats and market-related softness in certain categories.
Wiley’s news flow also features AI and data services developments, such as AI licensing projects for large language models, subscription knowledge feeds for corporate customers, and the launch and evolution of the Wiley AI Gateway. Press releases describe partnerships with organizations like Anthropic, Amazon Web Services, Perplexity, and Mistral AI, as well as collaborations with research-focused entities such as the European Space Agency’s Φ-lab.
Additional WLYB updates include capital allocation actions such as quarterly dividend declarations, long-running dividend increases, and changes to share repurchase allocations under the company’s authorization. Governance and leadership items, including Board appointments and executive leadership changes, are also disclosed. For readers tracking WLYB, this news stream provides insight into Wiley’s financial performance, strategic focus on AI and research intelligence, and ongoing commitment to science and learning.
Wiley (WLY) has launched Everything DiSC Worksmart, a new learning tool designed to help managers better implement insights from the Everything DiSC behavioral assessment in their daily work. The tool offers one-hour focused training sessions and on-demand action planning, addressing five key areas: giving constructive feedback, managing conflict, empowering teams, helping navigate change, and motivating teams.
Worksmart integrates with the Everything DiSC Catalyst™ platform and is positioned as the next step after completing the Everything DiSC Workplace assessment and facilitated group session. The launch comes as research shows that while effective managers can significantly improve employee retention and performance, over 50% lack proper training.
Wiley (NYSE: WLY) and Perplexity have announced a strategic partnership that integrates Wiley's educational content into Perplexity's AI search capabilities. As Perplexity's first education partner, Wiley will provide access to its specialized collections in nursing, business, and engineering through Perplexity's Enterprise Pro platform. The partnership targets educational institutions, with Texas A&M and Texas State University as pilot users, and several UK universities set to join.
The collaboration aims to address AI-generated misinformation concerns by incorporating verified, expert-reviewed content with proper attribution. Perplexity's platform will offer multilingual capabilities while citing English-language sources, making it valuable for institutions globally. Additionally, all Wiley employees will receive access to Perplexity Enterprise Pro licenses as part of the company's AI technology adoption strategy.
Wiley (WLY) has announced a groundbreaking collaboration with Amazon Web Services (AWS) to launch the first publisher-created generative AI agent for scientific literature search on AWS. The AI agent, set to debut at the 7th annual AWS Life Sciences Symposium on May 6, 2025, will enable researchers to conduct comprehensive full-text searches across Wiley's journal content.
The agent will be part of AWS's open source toolkit for healthcare and life sciences agents, initially providing AI-searchable access to creative commons licensed articles, including Cancer Medicine. This innovation promises to reduce research time from hours or days to minutes, delivering reliable and cited insights. The collaboration leverages AWS's Bedrock Agents technology and aligns with Wiley's responsible AI practices, focusing on human oversight, transparency, attribution, fairness, and governance.
Wiley (NYSE: WLY, WLYB) has declared a quarterly cash dividend of $0.3525 per share on its Class A and Class B Common Stock. The dividend will be paid on April 24, 2025, to shareholders of record on April 8, 2025.
The quarterly dividend equates to an annual dividend of $1.41 per share, representing an increase from $1.40 per share in Fiscal 2024. Notably, in June 2024, Wiley achieved a significant milestone by raising its dividend for the 31st consecutive year, demonstrating a long-standing commitment to shareholder returns.
Wiley (NYSE: WLY, WLYB) has declared a quarterly cash dividend of $0.3525 per share on its Class A and Class B Common Stock. The dividend will be paid on April 24, 2025, to shareholders of record on April 8, 2025.
The quarterly dividend equates to an annual dividend of $1.41 per share, representing an increase from $1.40 per share in Fiscal 2024. Notably, in June 2024, Wiley achieved a significant milestone by raising its dividend for the 31st consecutive year, demonstrating a long-standing commitment to shareholder returns.
Wiley (NYSE: WLY) has announced a partnership with Pi School to enhance the European Space Agency's Earth Virtual Expert (EVE) project. The company will provide access to a curated collection of Earth science research materials to train this AI-powered system.
EVE is a fine-tuned large language model being developed by Pi School with support from Imperative Space for ESA's Φ-lab. The system will be built by enhancing an existing AI language model with specialized Earth science knowledge, including content from Wiley's scientific journals, particularly the American Geophysical Union (AGU) publishing program, books, and Q&A courseware materials.
The initial phase will involve a pilot program with 200 experts from ESA and authorized external researchers to refine the system's capabilities. The platform aims to make Earth Observation information more accessible through an innovative web interface designed for both specialists and the general public.
Wiley (NYSE: WLY) reported strong Q3 2025 results with notable improvements in profitability despite revenue challenges. Third quarter revenue was $405 million, down from $461 million due to divested businesses, but adjusted revenue grew 1.2% at constant currency. Research segment showed robust performance with 5.2% growth.
Q3 Operating Income reached $52 million compared to ($46 million) prior year, with Adjusted Operating Income up 27%. The company executed significant agreements including India's 'one nation, one subscription' and a Brazil transformational agreement, expanding access to thousands of institutions. Research submissions increased 18% with output up 8%.
For FY2025, Wiley reaffirms outlook at mid-to-high end of ranges, projecting approximately 3% revenue growth and raising its FY2026 Adjusted EBITDA margin target to 25%+. The company's focus on scientific research and AI model development continues to drive growth, with notable expansion in open access, solutions, and AI licensing revenue.
Wiley (NYSE: WLY) has appointed Karen N. Madden, Ph.D. to its Board of Directors. Madden currently serves as Senior Vice President and Chief Technology Officer at MilliporeSigma, where she leads the Technology Roadmap and R&D strategy for the $9 billion Life Science Business.
As MilliporeSigma's CTO, Madden heads the Life Science Innovation Board and serves as U.S. Country Speaker for Merck KGaA, Darmstadt, Germany. Her prior experience includes serving as Senior Vice President and Chief Innovation Officer at PerkinElmer.
Madden holds a Ph.D. from Rutgers University, an M.S. from the University of Pennsylvania, and a B.A. from Boston University, all in chemistry-related fields. She currently serves on several industry boards including the Analytical, Life Science, and Diagnostics Association.